| Dr Brenda C Miller Edmonson, MD | |
|
910 Adams St Se, Suite 130, Huntsville, AL 35801-3730 | |
| (256) 265-6344 | |
| (256) 265-7965 |
| Full Name | Dr Brenda C Miller Edmonson |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 910 Adams St Se, Huntsville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336135268 | NPI | - | NPPES |
| 32640 | Other | AL | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 26946 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntsville Hospital | Huntsville, AL | Hospital |
| Entity Name | Edmonson Aesthetic Facial Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831356559 PECOS PAC ID: 9739250754 Enrollment ID: O20080619000232 |
News Archive
"Most people know that all surgery carries some risk," says Peter Fodor, President of the American Society for Aesthetic Plastic Surgery (ASAPS). "What is less well known is that airline travel carries risk. So people who combine the two need to take extra precautions," he says.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced additional positive results from an open-label pilot study of XOMA 052 in patients with uveitis of Behcet's disease who were suffering from vision-threatening exacerbations despite maximal doses of immunosuppressive medicines.
The University of California, Davis Department of Chemistry will spotlight a special focus on rare disease research with this year's 15th annual R. Bryan Miller Symposium. Experts in rare diseases will gather at the UC Davis Conference Center March 5 for a conference highlighting the opportunities and challenges in applying cutting edge technologies and "precision medicine" to better treat conditions that together affect millions of people, especially children.
Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the launch of its ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery.
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brenda C Miller Edmonson, MD 910 Adams St Se, Suite 130, Huntsville, AL 35801-3730 Ph: (256) 265-6344 | Dr Brenda C Miller Edmonson, MD 910 Adams St Se, Suite 130, Huntsville, AL 35801-3730 Ph: (256) 265-6344 |
News Archive
"Most people know that all surgery carries some risk," says Peter Fodor, President of the American Society for Aesthetic Plastic Surgery (ASAPS). "What is less well known is that airline travel carries risk. So people who combine the two need to take extra precautions," he says.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced additional positive results from an open-label pilot study of XOMA 052 in patients with uveitis of Behcet's disease who were suffering from vision-threatening exacerbations despite maximal doses of immunosuppressive medicines.
The University of California, Davis Department of Chemistry will spotlight a special focus on rare disease research with this year's 15th annual R. Bryan Miller Symposium. Experts in rare diseases will gather at the UC Davis Conference Center March 5 for a conference highlighting the opportunities and challenges in applying cutting edge technologies and "precision medicine" to better treat conditions that together affect millions of people, especially children.
Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the launch of its ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery.
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress.
› Verified 4 days ago
Dr. Brian Christopher Mulrooney, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1150 Eagletree Ln Sw, Huntsville, AL 35801 Phone: 256-533-8801 Fax: 256-533-8803 | |
Dr. Tarek Omar Persaud, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 401 Meridian St N, 400, Huntsville, AL 35801 Phone: 256-539-8851 Fax: 256-534-7203 | |
Robert Campbell Foster, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 401 Meridian St N Ste 200, Huntsville, AL 35801 Phone: 256-705-3937 Fax: 256-533-3213 | |
Dr. Lawrence Raymond Debarge, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1150 Eagletree Ln Sw, Huntsville, AL 35801 Phone: 256-533-8801 Fax: 256-533-8803 | |
Dr. Patricia Massengill Mccoy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 Providence Main St Nw, 2nd Floor Ste 1e, Huntsville, AL 35806 Phone: 256-382-2700 | |
Heather Ann Estopinal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 333 Whitesport Dr Sw Ste 101, Huntsville, AL 35801 Phone: 256-880-0667 | |
Jonathan Kevin Ramsey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3501 Memorial Pkwy Sw Ste 200, Huntsville, AL 35801 Phone: 256-533-0315 |